Palatin Technologies (PTN) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $6.02, -7.24% vs the prior close of $6.49.
- Volume 39.20K shares, 0.5x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
PTN slides 7.2% to $6.02, a 6-month low, 7 down days in a row. Closed at $6.02, -7.24% vs the prior close of $6.49. Day range $6.00–$6.93, opened at $6.93.
PTN daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — PTN slides 7.2% to $6.02, a 6-month low, 7 down days in a row
- Closed at $6.02, -7.24% vs the prior close of $6.49. Day range $6.00–$6.93, opened at $6.93.
- Volume was 39.20K shares, 0.5x its 50-day average of 78.75K — lighter than usual.
- Price is -39.5% vs its 50-day average ($9.94) and -58.8% vs its 200-day average ($14.62).
- 52-week range $5.61–$31.00; today's close sits at 2% of that range, 80.6% below the 52-week high.
- That makes 7 straight losses.
Oct 15, 2026 — PTN slides 12.5% to $6.49, a 6-month low, 6 down days in a row
- Closed at $6.49, -12.53% vs the prior close of $7.42. Day range $6.35–$8.00, opened at $7.40.
- Volume was 43.40K shares, 0.6x its 50-day average of 78.04K — lighter than usual.
- Price is -35.0% vs its 50-day average ($9.98) and -55.7% vs its 200-day average ($14.66).
- 52-week range $5.61–$31.00; today's close sits at 3% of that range, 79.1% below the 52-week high.
- That makes 6 straight losses.
Oct 14, 2026 — PTN slides 9.4% to $7.42, a 1-month low, 5 down days in a row
- Closed at $7.42, -9.40% vs the prior close of $8.19. Day range $7.25–$8.38, opened at $8.01.
- Volume was 49.30K shares, 0.6x its 50-day average of 77.28K.
- Price is -25.9% vs its 50-day average ($10.01) and -49.6% vs its 200-day average ($14.71).
- 52-week range $5.61–$31.00; today's close sits at 7% of that range, 76.1% below the 52-week high.
- That makes 5 straight losses.
Oct 13, 2026 — PTN slides 4.2% to $8.19, a 1-month low, 4 down days in a row
- Closed at $8.19, -4.21% vs the prior close of $8.55. Day range $8.14–$9.07, opened at $8.93.
- Volume was 14.20K shares, 0.2x its 50-day average of 77.24K — lighter than usual.
- Price is -18.3% vs its 50-day average ($10.02) and -44.5% vs its 200-day average ($14.74).
- 52-week range $5.61–$31.00; today's close sits at 10% of that range, 73.6% below the 52-week high.
- That makes 4 straight losses.
Oct 12, 2026 — PTN dips 0.6% to $8.55, a 1-month low, 3 down days in a row
- Closed at $8.55, -0.58% vs the prior close of $8.60. Day range $8.20–$8.80, opened at $8.55.
- Volume was 17.00K shares, 0.2x its 50-day average of 77.01K — lighter than usual.
- Price is -14.7% vs its 50-day average ($10.02) and -42.2% vs its 200-day average ($14.78).
- 52-week range $5.61–$31.00; today's close sits at 12% of that range, 72.4% below the 52-week high.
- That makes 3 straight losses.
Oct 9, 2026 — PTN slides 4.6% to $8.60, a 1-month low
- Closed at $8.60, -4.55% vs the prior close of $9.01. Day range $8.38–$9.20, opened at $8.93.
- Volume was 31.40K shares, 0.4x its 50-day average of 76.67K — lighter than usual.
- Price is -14.1% vs its 50-day average ($10.01) and -42.0% vs its 200-day average ($14.83).
- 52-week range $5.61–$31.00; today's close sits at 12% of that range, 72.3% below the 52-week high.
Oct 8, 2026 — PTN slides 5.4% to $9.01
- Closed at $9.01, -5.36% vs the prior close of $9.52. Day range $8.87–$9.86, opened at $9.86.
- Volume was 32.50K shares, 0.4x its 50-day average of 76.19K — lighter than usual.
- Price is -9.8% vs its 50-day average ($9.99) and -39.4% vs its 200-day average ($14.86).
- 52-week range $5.61–$31.00; today's close sits at 13% of that range, 70.9% below the 52-week high.
Oct 7, 2026 — PTN rises 1.2% to $9.52
- Closed at $9.52, +1.17% vs the prior close of $9.41. Day range $9.16–$9.87, opened at $9.87.
- Volume was 9.00K shares, 0.1x its 50-day average of 76.14K — lighter than usual.
- Price is -4.5% vs its 50-day average ($9.97) and -36.1% vs its 200-day average ($14.90).
- 52-week range $5.61–$31.00; today's close sits at 15% of that range, 69.3% below the 52-week high.
Oct 6, 2026 — PTN dips 0.7% to $9.41
- Closed at $9.41, -0.74% vs the prior close of $9.48. Day range $9.00–$9.88, opened at $9.00.
- Volume was 2.80K shares, 0.0x its 50-day average of 76.35K — lighter than usual.
- Price is -5.3% vs its 50-day average ($9.94) and -37.0% vs its 200-day average ($14.95).
- 52-week range $5.61–$31.00; today's close sits at 15% of that range, 69.6% below the 52-week high.
Oct 5, 2026 — PTN rises 1.6% to $9.48, 3 up days in a row
- Closed at $9.48, +1.61% vs the prior close of $9.33. Day range $8.96–$9.70, opened at $9.23.
- Volume was 13.00K shares, 0.2x its 50-day average of 76.27K — lighter than usual.
- Price is -4.3% vs its 50-day average ($9.90) and -36.8% vs its 200-day average ($15.01).
- 52-week range $5.61–$31.00; today's close sits at 15% of that range, 69.4% below the 52-week high.
- That makes 3 straight gains.
Oct 2, 2026 — PTN rises 3.0% to $9.33
- Closed at $9.33, +2.98% vs the prior close of $9.06. Day range $8.67–$9.45, opened at $9.02.
- Volume was 17.30K shares, 0.2x its 50-day average of 76.03K — lighter than usual.
- Price is -5.5% vs its 50-day average ($9.87) and -38.2% vs its 200-day average ($15.09).
- 52-week range $5.61–$31.00; today's close sits at 15% of that range, 69.9% below the 52-week high.
PTN latest news & SEC filings
Every SEC filing by or about PTN in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 28, 2026 · Form 10-K — Annual report
Annual report (audited full-year financial statements and business review)
Fiscal year ended Jun 30, 2026:
- Revenue: $13.19M
- Net income: -$8.38M (prior year -$17.31M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$2.96 (prior year -$32.15) (loss narrowed vs Jun 30, 2025)
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 5, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 5, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 5, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 3, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Jul 17, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 17, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 25, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Things to know before you trade PTN
- Last results release: Nov 14, 2024 (8-K Item 2.02). Previous ones: Oct 1, 2024, May 15, 2024, Feb 15, 2024. Based on that rhythm, the next report is likely around Feb 13, 2025 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.93% (largest 12.5%). That is a volatile stock.
- Liquidity: about 29.26K shares (≈$176.17K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $6.02 vs a range of $5.61–$31.00 (2% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:50 on Aug 12, 2025
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 4 sales; latest: Stephen T Wills sold 565 shares on Dec 24, 2025.
- Latest filings: 10-K Sep 28, 2026; 8-K Aug 3, 2026; 8-K May 18, 2026.
- Share count: 1.78M shares outstanding (Sep 25, 2026), +83.0% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
PTN market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 6.93 | 6.93 | 6.00 | 6.02 | 39.20K |
| Oct 15, 2026 | 7.40 | 8.00 | 6.35 | 6.49 | 43.40K |
| Oct 14, 2026 | 8.01 | 8.38 | 7.25 | 7.42 | 49.30K |
| Oct 13, 2026 | 8.93 | 9.07 | 8.14 | 8.19 | 14.20K |
| Oct 12, 2026 | 8.55 | 8.80 | 8.20 | 8.55 | 17.00K |
| Oct 9, 2026 | 8.93 | 9.20 | 8.38 | 8.60 | 31.40K |
| Oct 8, 2026 | 9.86 | 9.86 | 8.87 | 9.01 | 32.50K |
| Oct 7, 2026 | 9.87 | 9.87 | 9.16 | 9.52 | 9.00K |
| Oct 6, 2026 | 9.00 | 9.88 | 9.00 | 9.41 | 2.80K |
| Oct 5, 2026 | 9.23 | 9.70 | 8.96 | 9.48 | 13.00K |
| Oct 2, 2026 | 9.02 | 9.45 | 8.67 | 9.33 | 17.30K |
| Oct 1, 2026 | 8.74 | 9.12 | 8.68 | 9.06 | 33.00K |
| Sep 30, 2026 | 9.58 | 9.79 | 8.87 | 8.87 | 21.50K |
| Sep 29, 2026 | 9.54 | 9.69 | 9.04 | 9.12 | 32.80K |
| Sep 28, 2026 | 9.86 | 10.09 | 8.73 | 9.58 | 39.30K |
| Sep 25, 2026 | 9.85 | 10.35 | 9.50 | 10.10 | 22.40K |
| Sep 24, 2026 | 10.12 | 10.12 | 9.60 | 9.83 | 26.50K |
| Sep 23, 2026 | 10.79 | 10.79 | 9.81 | 10.27 | 41.20K |
| Sep 22, 2026 | 10.66 | 10.71 | 10.00 | 10.27 | 41.70K |
| Sep 21, 2026 | 11.03 | 11.73 | 10.22 | 10.22 | 57.80K |
About Palatin Technologies
Palatin Technologies (PTN) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in CRANBURY, NJ. State of incorporation: NJ. Fiscal year ends June 30. SEC CIK 911216.
PTN board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Alan W Dunton | Director | Aug 5, 2026 |
| Arlene Morris | Director | Aug 5, 2026 |
| John K A Prendergast | Director | Aug 5, 2026 |
| Carl Spana | President and CEO | Jul 17, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Carl Spana | President and CEO | Jul 17, 2026 |
| Stephen T Wills | Executive VP and CFO/COO | Jul 17, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Dec 24, 2025 | Stephen T Wills | Sale | 565 | $16.74 |
| Dec 24, 2025 | Stephen T Wills | Sale | 565 | $16.74 |
| Dec 24, 2025 | Stephen T Wills | Sale | 565 | $16.74 |
| Dec 24, 2025 | Stephen T Wills | Sale | 565 | $16.74 |
PTN financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Jun 30, 2026 | $13.19M | $-8.38M | -2.96 | $-13.53M |
| Jun 30, 2025 | — | $-17.31M | -32.15 | $-21.31M |
| Jun 30, 2024 | — | $-29.74M | -101.16 | $-31.46M |
| Jun 30, 2023 | — | $-24.04M | — | $-29.27M |
| Jun 30, 2022 | — | $-36.20M | — | $-29.92M |
Latest balance sheet: total assets $8.52M, total liabilities $1.84M, cash $7.49M (as of Jun 30, 2026).
PTN earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Nov 14, 2024 | 8-K Item 2.02 (results) | $53.50 |
| Oct 1, 2024 | 8-K Item 2.02 (results) | — |
| May 15, 2024 | 8-K Item 2.02 (results) | — |
| Feb 15, 2024 | 8-K Item 2.02 (results) | — |
| Nov 14, 2023 | 8-K Item 2.02 (results) | — |
| Oct 19, 2023 | 8-K Item 2.02 (results) | — |
| Sep 28, 2023 | 8-K Item 2.02 (results) | — |
| May 16, 2023 | 8-K Item 2.02 (results) | — |
| Feb 15, 2023 | 8-K Item 2.02 (results) | — |
| Nov 14, 2022 | 8-K Item 2.02 (results) | — |
| Sep 22, 2022 | 8-K Item 2.02 (results) | — |
| May 17, 2022 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on PTN
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.